Feasibility and antihypertensive effect of replacing regular salt with mineral salt -rich in magnesium and potassium- in subjects with mildly elevated blood pressure

Nutrition Journal

Volumn 10, Issue 1, 2011, Pages

  Sarkkinen, Essi S ^a,b   Kastarinen, Mika J ^b,c   Niskanen, Tarja H ^a   Karjalainen, Pia H ^a   Venäläinen, Taisa M ^a,b   Udani, Jay K ^d   Niskanen, Leo K ^b,c  

^a Oy foodfiles Ltd   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Central Finland Central Hospital   (Finland)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

blood pressure; high potassium and high magnesium salt; hypertension; low sodium; mineral salt; sodium reduction

Indexed keywords

INORGANIC SALT; PLACEBO; POTASSIUM; SMART SALT; SODIUM CHLORIDE; UNCLASSIFIED DRUG; CREATININE; MAGNESIUM; POTASSIUM CHLORIDE; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE VARIABILITY; BORDERLINE HYPERTENSION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAGNESIUM EXCRETION; MAJOR CLINICAL STUDY; MALE; POTASSIUM EXCRETION; RANDOMIZED CONTROLLED TRIAL; SALT INTAKE; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; URINE;

ADULT; AGED; BLOOD PRESSURE; CREATININE; FEMALE; HUMANS; HYPERTENSION; MAGNESIUM; MALE; MIDDLE AGED; POTASSIUM; POTASSIUM CHLORIDE; SODIUM; SODIUM CHLORIDE, DIETARY;

EID: 80052248021     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-10-88     Document Type: Article

References (38)

1. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. World Health Organization, International Society of Hypertension Writing Group, J Hypertens 2003 21 1983 1992 14597836
2. Trends in hypertension prevalence, awareness, treatment and control rates in United States adults between 1988-1994 and 1999-2004. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ, Hypertension 2008 52 818 27 10.1161/HYPERTENSIONAHA.108.113357 18852389
3. Prevalence, awareness and treatment of hypertension in Finland during 1982-2007. Kastarinen MJ, Antikainen RL, Peltonen M, Laatikainen T, Barengo NC, Jula A, et al. J Hypertens 2009 27 1552 9 10.1097/HJH.0b013e32832c41cd 19412128
4. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. N Engl J Med 2001 344 3 10 10.1056/NEJM200101043440101 11136953 (Pubitemid 32064838)
5. Dietary approaches to prevent and treat hypertension: A scientific statement from the American Heart Association. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM, Hypertension 2006 47 296 308 16434724 (Pubitemid 43189776)
6. Nonpharmacologic strategies for managing hypertension. Wexler R, Aukerman G, Am Fam Physician 2006 73 1953 6 16770925
7. Projected effect of dietary salt reductions on future cardiovascular disease. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. New Engl J Med 2010 362 590 9 10.1056/NEJMoa0907355 20089957
8. By how much does dietary salt reduction lower blood pressure? III - Analysis of data from trials of salt reduction. Law MR, Frost CD, Wald NJ, BMJ 1991 302 819 24 Erratum in BMJ 302,939 10.1136/bmj.302.6780.819 1827353
9. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. Midgley JP, Matthew AG, Greenwood CM, Logan AG, JAMA 1996 275 1590 7 10.1001/jama.275.20.1590 8622251 (Pubitemid 26154246)
10. Randomized trials of sodium reduction: an overview. Cutler JA, Follmann D, Allender PS, Am J Clin Nutr 1997 65 Suppl 2 643S 651S 9022560 (Pubitemid 27063065)
11. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. Graudal NA, Galløe AM, Garred P, JAMA 1998 279 1383 91 10.1001/jama.279.17.1383 9582047 (Pubitemid 28198806)
12. A meta-analysis of randomised controlled trials (RCT) among healthy normotensive and essential hypertensive elderly patients to determine the effect of high salt (NaCl) diet of blood pressure. Alam S, Johnson AG, J Hum Hypertens 1999 13 367 74 10.1038/sj.jhh.1000817 10408586 (Pubitemid 29286955)
13. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. He FJ, MacGregor GA, J Hum Hypertens 2002 16 761 70 10.1038/sj.jhh.1001459 12444537 (Pubitemid 36007929)
14. Effect of longer-term modest salt reduction on blood pressure. He FJ, MacGregor GA, Cochrane Database Syst Rev 2004 D004937
15. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Jürgens G, Graudal NA, Cochrane Database Syst Rev 2004 D004022
16. Replacing regular salt with sodium-reduced potassium- and magnesium-enriched mineral salt may offer non-pharmacological approach to lowering blood pressure. Neutel J, Am J Hypertens 1996 9 94A 10.1016/0895-7061(96)81769-9
17. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, et al. JAMA 1997 277 1624 32 10.1001/jama.277.20.1624 9168293 (Pubitemid 27231195)
18. Diet, blood pressure and hypertension. Hermansen K, Br J Nutr 2000 83 113 S119 10889801
19. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Jee SH, Miller ER, Guallar E, Singh VK, Appel LJ, Klag MJ, Am J Hypertens 2002 15 691 6 10.1016/S0895-7061(02) 02964-3 12160191 (Pubitemid 34804274)
20. Safety and effects of potassium- and magnesium-containing low sodium salt mixtures. Karppanen H, Tanskanen A, Tuomilehto J, Puska P, Vuori J, Jäntti V, et al. J Cardiovasc Pharmacol 1984 6 Suppl 1 236 43 6204148
21. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. Geleijnse JM, Witteman JC, Bak AA, den Breeijen JH, Grobbee DE, BMJ 1994 309 436 40 7920126 (Pubitemid 24252766)
22. Unchanged central hemodynamics after six months of moderate sodium restriction with or without potassium supplement in essential hypertension. Omvik P, Myking OL, Blood Press 1995 4 32 41 10.3109/08037059509077565 7735495
23. Effects of dietary sodium substitution with potassium and magnesium in hypertensive type II diabetics: a randomised blind controlled parallel study. Gilleran G, O'Leary M, Bartlett WA, Vinall H, Jones AF, Dodson PM, J Hum Hypertens 1996 10 517 21 8895035 (Pubitemid 26345658)
24. Reduction in blood pressure with a sodium-reduced, potassium- and magnesium-enriched mineral salt in subjects with mild essential hypertension. Kawasaki T, Itoh K, Kawasaki M, Hypertens Res 1998 21 235 43 10.1291/hypres.21.235 9877516 (Pubitemid 29017335)
25. Effect of a mineral salt diet on 24-h blood pressure monitoring in elderly hypertensive patients. Katz A, Rosenthal T, Maoz C, Peleg E, Zeidenstein R, Levi Y, J Hum Hypertens 1999 13 777 80 10.1038/sj.jhh.1000837 10578223 (Pubitemid 29533011)
26. Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. China Salt Substitute Study Collaborative Group, J Hypertens 2007 25 2011 8 17885542
27. Systematic review of long term effects of advice to reduce dietary salt in adults. Hooper L, Bartlett C, Davey Smith G, Ebrahim S, BMJ 2002 325 628 10.1136/bmj.325.7365.628 12242173
28. Salt restriction for the prevention of cardiovascular disease. Klaus D, Hoyer J, Middeke M, Dtsch Arztebl Int 2010 107 457 462 20644699
29. Trends in lifestyle factors affecting blood pressure in hypertensive and normotensive Finns during 1982-2002. Kastarinen M, Laatikainen T, Salomaa V, Jousilahti P, Antikainen R, Tuomilehto J, et al. J Hypertens 2007 25 299 305 10.1097/HJH.0b013e328010ca88 17211236 (Pubitemid 46071927)
30. Sodium in the Finnish diet: 20-year trends in urinary sodium excretion among the adult population. Laatikainen T, Pietinen P, Valsta L, Sundvall J, Reinivuo H, Tuomilehto J, Eur J Clin Nutr 2006 60 965 70 10.1038/sj.ejcn.1602406 16482074 (Pubitemid 44161017)
31. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. Cappuccio FP, MacGregor GA, J Hypertens 1991 9 465 473 10.1097/00004872-199105000-00011 1649867
32. The association between blood pressure, age and dietary sodium and potassium: a population study. Khaw KT, Barrett-Connor E, Circulation 1988 77 53 61 10.1161/01.CIR.77.1.53 3257173 (Pubitemid 18031000)
33. Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind, cross-over study. Wirell MP, Wester PO, Stegmayr BG, J Intern Med 1994 236 189 95 10.1111/j.1365-2796.1994. tb01282.x 7913949 (Pubitemid 24246976)
34. Reduction of blood pressure with oral magnesium supplementation in women with mild and moderate hypertension. Witteman JCM, Grobbee DE, Derkx FHM, Bouillon R, de Bruijn AM, Hofman A, Am J Clin Nutr 1994 60 129 135 8017327 (Pubitemid 24215766)
35. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. Sanjuliani AF, de Abreu Fagundes VG, Francischetti EA, Int J Cardiol 1996 56 117 83
36. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Itoh K, Kawasaka T, Nakamura M, Br J Nutr 1997 78 737 50 10.1079/BJN19970191 9389897 (Pubitemid 27483017)
37. Effects of magnesium supplementation in hypertensive patients: assessment by office, home and ambulatory blood pressure. Kawano Y, Matsuoka H, Takishita S, Omae T, Hypertension 1998 32 260 5 9719052 (Pubitemid 28376482)
38. Methodology of sodium sensitivity assessment. Grobbee DE, Hypertension 1991 17 109 114